Coronado Industries Announces European Study Proves ``PNT'' to be Safe and Effective.Business Editors FOUNTAIN HILLS, Ariz.--(BUSINESS WIRE)--June 13, 2002 Coronado Industries Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :CDIK), a manufacturer of proprietary pneumatic devices for the effective treatment of glaucoma, today announced they have received approximately 300 pages of raw data from the European Study. After initial review of this data, Coronado Industries' medical director, John T. LiVecchi, M.D., and study director, Leo Leo, in astronomy Leo [Lat.,=the lion], northern constellation lying S of Ursa Major and on the ecliptic (apparent path of the sun through the heavens) between Cancer and Virgo; it is one of the constellations of the zodiac. D. Bores, M.D., both stated, "This information definitely shows Pneumatic Trabeculoplasty (PNT PNT Point PNT Paint (MacPaint graphic file format) PNT Patient PNT Pentagon (Washington, DC; US DoD) PNT Positioning, Navigation and Timing PNT Prime Number Theorem PNT Phenytoin (TM)) to be both safe and effective." Coronado Industries will have the raw data sent to an independent bio-statistician for analysis and summary of this study. When completed, the data will be packaged with other materials and will be submitted to several interested companies. Forward-looking statements in this release are made pursuant to the "safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. " provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Investors are cautioned that such forward-looking statements involve risks and uncertainties, including without limitation, continued acceptance of the company's products, increased levels of competition for the company, new products and technological changes, the company's dependence on third-party suppliers, and other risks detailed from time to time in the company's periodic reports filed with the Securities and Exchange Commission. |
|
||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion